Evidence map›Paper›PMID 18674534›Full record

ArticleExperimental cell research2008

Disruption of cell-matrix interactions by heparin enhances mesenchymal progenitor adipocyte differentiation.

Weijun Luo, Hailu Shitaye, Michael Friedman, Christina N Bennett, Joshua Miller, Ormond A Macdougald, Kurt D Hankenson

Abstract read
In one paragraph

Article in Experimental cell research, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Evolution of the Marrow Adipose Tissue Microenvironment.Calcified tissue international · 2017
    Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Nanotopographical control of stem cell differentiation.Journal of tissue engineering · 2010
    Article
  18. Thrombospondin-2 is an endogenous adipocyte inhibitor.Matrix biology : journal of the International Society for Matrix Biology · 2010
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Weijun LuoDepartment of Biomedical Engineering, Medical School, University of Michigan, USA.
Hailu Shitaye
Michael Friedman
Christina N Bennett
Joshua Miller
Ormond A Macdougald
Kurt D Hankenson
University of Michigan–Ann Arbor · USUniversity of Pennsylvania · US

Funding

Endosteal Adipose in Age-Associated OsteopeniaR01AR054714 · NIAMS · UNIVERSITY OF PENNSYLVANIA · PI HANKENSON, KURT DAVID · 2006 to 2010
$1.9M
BMP6 Induction of Human Mesenchymal Stem Cell Osteoblast DifferentiationR01DE017471 · NIDCR · UNIVERSITY OF PENNSYLVANIA · PI HANKENSON, KURT DAVID · 2006 to 2010
$1.9M
Matricellular Proteins and Mesenchymal Stem CellsR01AR049682 · NIAMS · UNIVERSITY OF PENNSYLVANIA · PI HANKENSON, KURT DAVID · 2002 to 2006
$1.2M
NIAMS NIH HHS AR049682NIAMS NIH HHS R01 AR049682NIAMS NIH HHS R01 AR054714NIDCR NIH HHS DE017471NIDCR NIH HHS R01 DE017471
6 · The paper itself

Abstract

Differentiation of marrow-derived mesenchymal progenitors to either the osteoblast or adipocyte lineage is reciprocally regulated. Factors that promote osteoblastogenesis inhibit adipogenesis, while adipogenic factors are inhibitory to osteoblast differentiation. Heparin, a soluble glycosaminoglycan, inhibits bone formation in vivo and osteoblast cell differentiation and function in vitro, and has been shown to promote adipocyte differentiation. To elucidate the role that heparin plays in the adipogenic induction of murine mesenchymal progenitors, we studied immortalized marrow stromal cells (IM-MSC), the MSC cell line, ST2, and 3T3L1 pre-adipocytes. Heparin alone was not sufficient to induce adipogenesis, but enhanced the induction under a variety of adipogenic cocktails. This effect was both dose- and time-dependent. Heparin showed a positive effect at concentrations > 0.1 microg/ml when applied before day 3 during the induction course. Heparin's effect on adipogenesis was independent of cell proliferation, cell density, and extracellular lipid. This effect is likely related to the unique structure of heparin because another polyanionic glycosaminoglycan, dextran sulfate, did not promote adipogenic differentiation. Heparin treatment altered morphology and adhesion characteristics of progenitor cells, resulting in cell rounding and aggregation. As well, heparin counteracted the known inhibitory effect of fibronectin on adipogenesis and decreased basal focal adhesion kinase and paxillin phosphorylation. We conclude that heparin-mediated disruption of cell-matrix adhesion enhances adipogenic potential.

Indexed as

AdipocytesAnimalsBase SequenceBlotting, WesternCell AdhesionCell DifferentiationCells, CulturedDextran SulfateDose-Response Relationship, DrugExtracellular MatrixHeparinMesenchymal Stem CellsMiceMolecular Sequence DataReverse Transcriptase Polymerase Chain ReactionSignal TransductionDextran SulfateHeparin

Identifiers

PMID18674534
PMCPMC3179914
OpenAlexW2110114833

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.